To evaluate TMEM106A expression as a prognostic predictor for HCC patients after surgical resection, TMEM106A expression was assessed by a tissue microarray composed of a cohort of 242HCC patients. The gene discussed is TMEM106A; the disease is hepatocellular carcinoma.